Biocept this week said it has named Lyle Arnold senior vice president and chief scientific officer and Michael Dunn senior vice president of corporate development.
Arnold is a founder and director of Aegea Biotechnologies and was previously vice president of research at Gen-Probe. He has also held senior scientific and management positions at Genta, Synteni, and Incyte Genomics and was a co-founder of Molecular Biosystems and Oasis Biosciences. He also serves on the board of directors of Asuragen.
Gilbert Omenn has been appointed to the board of directors of the Hastings Center.
A professor of internal medicine, human genetics, and public health at the University of Michigan, Ommen is also principal investigator of the Michigan Proteomics Alliance for Cancer Research and leader of the Human Proteome Organization's Human Plasma Proteome Project. He also sits on the board of directors of Amgen and served as associate director of the Office of Management and Budget during the Carter administration.
The National Academy of Sciences this week released the names of its 72 new members, including a number of researchers working in proteomics. The list of new inductees includes:
David Bartel, an investigator at the Howard Hughes Medical Institute and professor of biology at the Massachusetts Institute of Technology;
Arthur Beaudet, the Henry and Emma Meyer Professor and chair, department of molecular and human genetics at Baylor College of Medicine;
George Church, director of the Lipper Center for Computational Genetics and professor of genetics at Harvard Medical School;
A full list of new members can be found here.
Matthew Potter has resigned from his position as VP of sales at Pressure Biosciences and will leave the company as of May 13. The company said it has struck an agreement with Potter to buy back his outstanding options of the firm's common stock.